Annual report pursuant to Section 13 and 15(d)

The following sets forth the number of shares of common stock underlying outstanding convertible preferred stock, options, warrants, and convertible notes that have been excluded from the computation of loss per common share: (Details)

v3.22.2
The following sets forth the number of shares of common stock underlying outstanding convertible preferred stock, options, warrants, and convertible notes that have been excluded from the computation of loss per common share: (Details) - $ / shares
12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Restricted stock 24,037,298 38,315,634
Exercise price (in dollars per share) $ 0.0004  
Equity Option [Member]    
Restricted stock [1] 13,700,000 16,300,000
Number of stock excluded 2,000,000  
Exercise price (in dollars per share) $ 0.0004  
Restricted Stock [Member]    
Restricted stock [1] 187,510
Warrant [Member]    
Restricted stock 10,149,788 6,769,635
Convertible Notes [Member]    
Restricted stock (0) 245,999
Series A Preferred Stock [Member]    
Restricted stock 15,000,000
[1] The Company has excluded 2,000,000 stock options, with an exercise price of $0.0004, from its anti-dilutive securities as these shares have been included in our determination of basic loss per share as they represent shares issuable for little or no cash consideration upon the satisfaction of certain conditions pursuant to ASC 260-10-45-14.